Trial intelligence / Profile preview

Influence of sirolimus introduction on inflammatory balance in renal transplant recipients

2008-008895-15Phase 4Active

Sponsor
Hospices Civils de Lyon
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sirolimus in Kidney allograft status (RTx), sponsored by Hospices Civils de Lyon. Primary endpoint: Sirolimus-related adverse effects. Started Mar 2009; status: active.

02

Drugs

sirolimus
03

Conditions

Kidney allograft status (RTx)

Beyond the preview

Go deeper on 2008-008895-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008895-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call